What's in Alloksys Life Sciences B.V.'s pipeline?

Alloksys Life Sciences B.V. has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Alloksys Life Sciences B.V.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alloksys-life-sciences-b-v.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Alloksys Life Sciences B.V. — Portfolio Competitive Intelligence Brief

Alloksys Life Sciences B.V. pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
bIAP bolus and 8h infusion	bIAP bolus and 8h infusion	phase 3	Caspase-1 inhibitor	Caspase-1	Inflammatory diseases
placebo bolus and 8h infusion	placebo bolus and 8h infusion	phase 3

Therapeutic area mix

Inflammatory diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Alloksys Life Sciences B.V.:

Cite this brief

Drug Landscape (2026). Alloksys Life Sciences B.V. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alloksys-life-sciences-b-v. Accessed 2026-05-14.